| 2018 | MET in gastric cancer with liver metastasis: The relationship between MET amplification and Met overexpression in primary stomach tumors and liver metastasis. | JOURNAL OF SURGICAL ONCOLOGY |
| 2018 | Marked Loss of Muscle, Visceral Fat, or Subcutaneous Fat After Gastrectomy Predicts Poor Survival in Advanced Gastric Cancer: Single-Center Study from the CLASSIC Trial | ANNALS OF SURGICAL ONCOLOGY |
| 2018 | A Prediction Model of Tumor Progression and Survival in HER2-Positive Metastatic Gastric Cancer Patients Treated with Trastuzumab and Chemotherapy | AAPS JOURNAL |
| 2018 | Efficacy and safety of pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma: Pooled analyses after long-term follow-up in KEYNOTE-012 | BRITISH JOURNAL OF CANCER |
| 2018 | Alpha-fetoprotein kinetics in patients with hepatocellular carcinoma receiving ramucirumab or placebo: An analysis of the phase 3 REACH study | BRITISH JOURNAL OF CANCER |
| 2018 | The prognostic value of volume-based parameters using<sup>18</sup>F-FDG PET/CT in gastric cancer according to HER2 status | GASTRIC CANCER |
| 2018 | Subgroup analysis of East Asian patients in REGARD: A phase III trial of ramucirumab and best supportive care for advanced gastric cancer | ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY |
| 2018 | Forty-nine gastric cancer cell lines with integrative genomic profiling for development of c-MET inhibitor | INTERNATIONAL JOURNAL OF CANCER |
| 2018 | Pembrolizumab in Asia-Pacific patients with advanced head and neck squamous cell carcinoma: Analyses from KEYNOTE-012
| CANCER SCIENCE |
| 2018 | Prognostic implications of polycomb proteins ezh2, suz12, and eed1 and histone modification by H3K27me3 in sarcoma.
| BMC CANCER |
| 2017 | PTEN loss and level of HER2 amplification is associated with trastuzumab resistance and prognosis in HER2-positive gastric cancer
| ONCOTARGET |
| 2017 | Feasibility of quantifying SDC2 methylation in stool DNA for early detection of colorectal cancer
| CLINICAL EPIGENETICS |
| 2017 | A non-randomized, open-label, single-arm, Phase 2 study of emibetuzumab in Asian patients with MET diagnostic positive, advanced gastric cancer
| CANCER CHEMOTHERAPY AND PHARMACOLOGY |
| 2017 | Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial | LANCET |
| 2017 | A phase 1, open label, dose escalation study to investigate the safety, tolerability, and pharmacokinetics of MG1102 (apolipoprotein(a) Kringle V) in patients with solid tumors | INVESTIGATIONAL NEW DRUGS |
| 2017 | A First-Time-in-Human Study of GSK2636771, a Phosphoinositide 3 Kinase Beta-Selective Inhibitor, in Patients with Advanced Solid Tumors | CLINICAL CANCER RESEARCH |
| 2017 | Quality of life on TSU-68: Combination of docetaxel and TSU-68, an oral antiangiogenic agent, in patients with metastatic breast cancer previously treated with anthracycline | ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY |
| 2017 | Cardiotoxicity of trastuzumab in patients with HER2-positive gastric cancer
| ONCOTARGET |
| 2017 | HER2 Status in Advanced or Metastatic Gastric, Esophageal, or Gastroesophageal Adenocarcinoma for Entry to the TRIO-013/LOGiC Trial of Lapatinib.
| MOLECULAR CANCER THERAPEUTICS |
| 2017 | Changes in telomerase activity due to alternative splicing of human telomerase reverse transcriptase in colorectal cancer
| ONCOLOGY LETTERS |
| 2017 | Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib: Patient-focused outcome results from the randomised phase III REACH study | EUROPEAN JOURNAL OF CANCER |
| 2017 | Complementary utility of targeted next-generation sequencing and immunohistochemistry panels as a screening platform to select targeted therapy for advanced gastric cancer
| ONCOTARGET |
| 2017 | Modulation of HAT activity by the BRCA2 N372H variation is a novel mechanism of paclitaxel resistance in breast cancer cell lines | BIOCHEMICAL PHARMACOLOGY |
| 2017 | Effects of hormone receptor status on the durable response of trastuzumab-based therapy in metastatic breast cancer | BREAST CANCER RESEARCH AND TREATMENT |
| 2017 | Trastuzumab emtansine versus taxane use for previously treated HER2-positive locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma (GATSBY): an international randomised, open-label, adaptive, phase 2/3 study | LANCET ONCOLOGY |
| 2017 | ABCB1 2677G>T/A variant enhances chemosensitivity to anti-cancer agents acting on microtubule dynamics through LAMP1 inhibition | BIOCHEMICAL PHARMACOLOGY |
| 2017 | Differential Prognostic Implications of Gastric Signet Ring Cell Carcinoma: Stage Adjusted Analysis From a Single High-volume Center in Asia
| ANNALS OF SURGERY |
| 2017 | Prevalence and prognostic implications of psychological distress in patients with gastric cancer
| BMC CANCER |
| 2017 | Depth of response is a significant predictor for long-term outcome in advanced gastric cancer patients treated with trastuzumab
| ONCOTARGET |
| 2016 | A novel TP53-KPNA3 translocation defines a de novo treatment-resistant clone in osteosarcoma
| COLD SPRING HARBOR MOLECULAR CASE STUDIES |
| 2016 | Next-generation sequencing reveals somatic mutations that confer exceptional response to everolimus
| ONCOTARGET |
| 2016 | High-risk clinicopathological features and their predictive significance in Korean patients with stage II colon cancer | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY |
| 2016 | Comprehensive expression profiles of gastric cancer molecular subtypes by immunohistochemistry: implications for individualized therapy
| ONCOTARGET |
| 2016 | Lapatinib in Combination With Capecitabine Plus Oxaliplatin in Human Epidermal Growth Factor Receptor 2-Positive Advanced or Metastatic Gastric, Esophageal, or Gastroesophageal Adenocarcinoma: TRIO-013/LOGiC--A Randomized Phase III Trial | JOURNAL OF CLINICAL ONCOLOGY |
| 2016 | Prognostic implications of PD-L1 expression in patients with soft tissue sarcoma
| BMC CANCER |
| 2016 | Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial | LANCET ONCOLOGY |
| 2016 | Prognostic value of (18)F-fluorodeoxyglucose positron emission tomography in patients with gastric neuroendocrine carcinoma and mixed adenoneuroendocrine carcinoma. | ANNALS OF NUCLEAR MEDICINE |
| 2016 | Genetic alterations and their clinical implications in gastric cancer peritoneal carcinomatosis revealed by whole-exome sequencing of malignant ascites
| ONCOTARGET |
| 2016 | Circulating Plasma Biomarkers for TSU-68, an Oral Antiangiogenic Agent, in Patients with Metastatic Breast Cancer.
| CANCER RESEARCH AND TREATMENT |
| 2016 | Droplet digital polymerase chain reaction detection of HER2 amplification in formalin fixed paraffin embedded breast and gastric carcinoma samples. | EXPERIMENTAL AND MOLECULAR PATHOLOGY |
| 2016 | Cumulative Metformin Use and Its Impact on Survival in Gastric Cancer Patients After Gastrectomy | ANNALS OF SURGERY |
| 2015 | The Clinicopathologic Features and Prognostic Impact of ALK Positivity in Patients with Resected Gastric Cancer | ANNALS OF SURGICAL ONCOLOGY |
| 2015 | The Impact of Coping Styles on Psychological Distress and Quality of Life in Korean Patients with Cancer
| Korean Journal of Psycho-Oncology (정신종양학회지) |
| 2015 | Results of a Phase II Study to Evaluate the Efficacy of Docetaxel and Carboplatin in Metastatic Malignant Melanoma Patients Who Failed First-Line Therapy Containing Dacarbazine
| CANCER RESEARCH AND TREATMENT |
| 2015 | Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial | LANCET ONCOLOGY |
| 2015 | LAMC2 enhances the metastatic potential of lung adenocarcinoma | CELL DEATH AND DIFFERENTIATION |
| 2015 | Clinicopathological features and prognostic significance of HER2 expression in gastric cancer | ONCOLOGY |
| 2015 | Do Recent Advances in Diagnostic and Therapeutic Procedures Negate the Benefit of Postmastectomy Radiotherapy in N1 Patients With a Low Risk of Locoregional Recurrence?
| MEDICINE |
| 2015 | Dovitinib (TKI258), a multi-target angiokinase inhibitor, is effective regardless of KRAS or BRAF mutation status in colorectal cancer
| AMERICAN JOURNAL OF CANCER RESEARCH |
| 2015 | PINCH-2 presents functional copy number variation and suppresses migration of colon cancer cells by paracrine activity | INTERNATIONAL JOURNAL OF CANCER |
http://orcid.org/0000-0002-0920-9471
(7404006815)
